Foundation

Share on

Cavalieri Ottolenghi Foundation (non-profit corporation recognised by Regione Piemonte) aims to sustain research programmes in the field of Neurosciences.

The Foundation started out with Annetta Cavalieri Ottolenghi's donation to University of Torino.
The Foundation's goal is, as stated in its statute, to "deepen the current knowledge regarding the interdependence between physical and chemical conditions of the human body, and mental manifestations, or rather investigate the causes of mental illness, ultimately providing a cure".

The Neuroscience Institute Cavalieri Ottolenghi Foundation (NICO) intends to provide high quality neuroscientific research, with a specific interest in prevention, diagnostics, and cure of neurological disorders. Following these principles, research at NICO focuses on mechanisms underlying neuronal maturation, and errors that might cause mental retardation.

The Foundation's headquarters and laboratories had been at the Department of Clinical and Biological Sciences, Faculty of Medicine, University of Torino, for many years. Since 2010, offices and laboratories are located in the Foundation's new building, in the campus of the Azienda Ospedaliero-Universitaria San Luigi Gonzaga, in Orbassano (near Torino).

Events & Meetings

21 september 2018

NICO Progress Report - INN Open Neuroscience Forum

Our young researchers present their work to collegues. From February to December, every two weeks, on friday at 2:00 pm
Seminars Room, NICO

26 september 2018

Vision4D MULTIDIMENSIONAL QUANTITATIVE IMAGE ANALYSIS

WORKSHOP
Maurizio Abbate, ARIVIS
Prof. Ferdinando Di Cunto, NICO - UNITO

16 february 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.